サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1714251

大型分子バイオ分析技術市場- 世界の産業規模、シェア、動向、機会、予測、製品・サービス別（製品、サービス）、用途別、地域別、競合別セグメント、2020-2030F

Large Molecule Bioanalytical Technologies Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Products & Services (Product, Service), By Application, By Region and Competition, 2020-2030F

出版日
ページ情報
英文 184 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円

こちらのレポートには、数時間（ご購入金額の10%）分のアナリストへの質問／追加調査サービスが含まれております。

大型分子バイオ分析技術市場- 世界の産業規模、シェア、動向、機会、予測、製品・サービス別（製品、サービス）、用途別、地域別、競合別セグメント、2020-2030F
出版日: 2025年04月25日
発行: TechSci Research
ページ情報: 英文 184 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

大型分子バイオ分析技術の世界市場規模は2024年に95億4,000万米ドル、2030年には172億1,000万米ドルに達すると予測され、予測期間中のCAGRは10.31%と堅調な伸びを記録します。

市場成長の原動力となっているのは、生物学的製剤とバイオシミラーのパイプラインが拡大していることと、慢性疾患や生命を脅かす疾患の治療において低分子医薬品よりも生物学的製剤が好まれるようになっていることです。このような先進的な治療薬には、医薬品開発の全段階にわたって、正確な特性評価、定量化、バリデーションを行うための精密な分析ツールが必要です。モノクローナル抗体、組換えタンパク質、遺伝子治療の使用増加により、製薬会社や研究機関はハイスループットの高感度技術への投資を促しています。ハイブリッド分析プラットフォーム、デジタル自動化、AI統合などの新たな動向は、バイオ分析ワークフローをさらに変革しつつあります。この分野は技術進歩の恩恵を受ける一方で、高額な設備投資や厳しい規制基準に関連する課題に直面し続けています。生物製剤は複雑であるため、分析手法の継続的な革新と標準化も必要であり、バイオ医薬品業界における高度なバイオ分析技術の重要な役割が強化されています。

市場概要
予測期間 2026-2030
市場規模：2024年 95億4,000万米ドル
市場規模：2030年 172億1,000万米ドル
CAGR：2025年～2030年 10.31%
急成長セグメント 細胞・遺伝子治療
最大市場 北米

市場促進要因

生物製剤とバイオシミラーの需要拡大

主な市場課題

高度な分析機器の高コスト

主要市場動向

ハイブリッド分析技術の採用

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界の大型分子バイオ分析技術市場展望

  • 市場規模・予測
    • 金額別
  • 市場シェア・予測
    • 製品・サービス別（製品（消耗品・付属品、機器、試薬・キット）、サービス）
    • 用途別（生物製剤、オリゴヌクレオチド由来医薬品・分子、ウイルスベクター、細胞・遺伝子治療、ナノ粒子・ポリマー、その他）
    • 企業別（2024）
    • 地域別
  • 市場マップ

第6章 北米の大型分子バイオ分析技術市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 北米：国別分析
    • 米国
    • メキシコ
    • カナダ

第7章 欧州の大型分子バイオ分析技術市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 欧州：国別分析
    • フランス
    • ドイツ
    • 英国
    • イタリア
    • スペイン

第8章 アジア太平洋地域の大型分子バイオ分析技術市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • アジア太平洋地域：国別分析
    • 中国
    • インド
    • 韓国
    • 日本
    • オーストラリア

第9章 南米の大型分子バイオ分析技術市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 南米：国別分析
    • ブラジル
    • アルゼンチン
    • コロンビア

第10章 中東・アフリカの大型分子バイオ分析技術市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 中東・アフリカ：国別分析
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦

第11章 市場力学

  • 促進要因
  • 課題

第12章 市場動向と発展

  • 合併と買収
  • 製品上市
  • 最近の動向

第13章 ポーターのファイブフォース分析

  • 業界内の競合
  • 新規参入の可能性
  • サプライヤーの力
  • 顧客の力
  • 代替品の脅威

第14章 競合情勢

  • Intertek Group plc
  • F. Hoffmann-La Roche Ltd
  • Bio-Rad Laboratories, Inc.
  • Solvias
  • Bio-Techne
  • Waters Corporation
  • Verder Scientific GmbH & Co. KG
  • Charles River Laboratories
  • Merck KGaA
  • Cergentis B.V.

第15章 戦略的提言

第16章 調査会社について・免責事項

目次
Product Code: 28302

The global market for large molecule bioanalytical technologies was valued at USD 9.54 billion in 2024 and is projected to reach USD 17.21 billion by 2030, registering a robust CAGR of 10.31% during the forecast period. Market growth is being fueled by the expanding pipeline of biologics and biosimilars, along with the increasing preference for biologic therapies over small molecules in treating chronic and life-threatening conditions. These advanced therapeutics require precise analytical tools for accurate characterization, quantification, and validation across all phases of drug development. The rise in the use of monoclonal antibodies, recombinant proteins, and gene therapies is prompting pharmaceutical companies and research organizations to invest in high-throughput, sensitive technologies. Emerging trends such as hybrid analytical platforms, digital automation, and AI integration are further transforming bioanalytical workflows. While the sector benefits from technological progress, it continues to face challenges related to high capital investment and stringent regulatory standards. The complexity of biologics also necessitates ongoing innovation and standardization in analytical methodologies, reinforcing the critical role of advanced bioanalytical technologies in the biopharmaceutical industry.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 9.54 Billion
Market Size 2030USD 17.21 Billion
CAGR 2025-203010.31%
Fastest Growing SegmentCell & Gene Therapy
Largest MarketNorth America

Key Market Drivers

Growing Demand for Biologics and Biosimilars

The global shift toward biologics and biosimilars as preferred therapeutic modalities is a key driver of demand for large molecule bioanalytical technologies. Biologics, including monoclonal antibodies and therapeutic proteins, offer high specificity and efficacy in treating complex conditions such as cancer and autoimmune diseases. As these therapies require extensive analytical testing throughout their development and regulatory lifecycle, the need for reliable, high-precision bioanalytical platforms has grown significantly. Additionally, regulatory mandates for biosimilar comparability studies further intensify the demand for advanced analytical solutions to evaluate safety, efficacy, and quality. The increasing adoption of biologics across diverse therapeutic areas ensures a sustained need for robust, sensitive, and scalable bioanalytical technologies.

Key Market Challenges

High Costs of Advanced Analytical Instruments

The adoption of large molecule bioanalytical technologies is often hindered by the high costs associated with procuring and operating advanced instruments. Technologies such as LC-MS/MS and surface plasmon resonance systems require substantial capital investment and ongoing operational expenses. These costs include maintenance, calibration, consumables, and software licensing. For small and mid-sized laboratories or emerging biotech firms, such financial demands can be a major constraint. This challenge is compounded by the need for highly skilled personnel to operate and maintain these systems, limiting market penetration in resource-constrained settings.

Key Market Trends

Adoption of Hybrid Analytical Techniques

An emerging trend in the market is the increased use of hybrid analytical methods, particularly those that integrate ligand-binding assays with LC-MS/MS. This combination enhances both sensitivity and specificity, making it ideal for analyzing complex biologics such as monoclonal antibodies and fusion proteins. These techniques are especially useful in pharmacokinetics, pharmacodynamics, and immunogenicity studies, where the detection of trace levels of analytes in complex biological samples is critical. Regulatory bodies are acknowledging the value of these integrated approaches, further promoting their adoption in both early-stage research and clinical development.

Key Market Players

  • Intertek Group plc
  • F. Hoffmann-La Roche Ltd
  • Bio-Rad Laboratories, Inc.
  • Solvias
  • Bio-Techne
  • Waters Corporation
  • Verder Scientific GmbH & Co. KG
  • Charles River Laboratories
  • Merck KGaA
  • Cergentis B.V.

Report Scope:

In this report, the Global Large Molecule Bioanalytical Technologies Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Large Molecule Bioanalytical Technologies Market, By Products & Services:

  • Product

Consumables & Accessories

Instruments

Reagents & Kits

  • Service

Large Molecule Bioanalytical Technologies Market, By Application:

  • Biologics
  • Oligonucleotide Derived Drugs & Molecules
  • Viral Vector
  • Cell & Gene Therapy
  • Nanoparticles & Polymers
  • Others

Large Molecule Bioanalytical Technologies Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Large Molecule Bioanalytical Technologies Market.

Available Customizations:

Global Large Molecule Bioanalytical Technologies Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Large Molecule Bioanalytical Technologies Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Products & Services (Product (Consumables & Accessories, Instruments, Reagents & Kits), Service)
    • 5.2.2. By Application (Biologics, Oligonucleotide Derived Drugs & Molecules, Viral Vector, Cell & Gene Therapy, Nanoparticles & Polymers, Others)
    • 5.2.3. By Company (2024)
    • 5.2.4. By Region
  • 5.3. Market Map

6. North America Large Molecule Bioanalytical Technologies Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Products & Services
    • 6.2.2. By Application
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Large Molecule Bioanalytical Technologies Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Products & Services
        • 6.3.1.2.2. By Application
    • 6.3.2. Mexico Large Molecule Bioanalytical Technologies Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Products & Services
        • 6.3.2.2.2. By Application
    • 6.3.3. Canada Large Molecule Bioanalytical Technologies Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Products & Services
        • 6.3.3.2.2. By Application

7. Europe Large Molecule Bioanalytical Technologies Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Products & Services
    • 7.2.2. By Application
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Large Molecule Bioanalytical Technologies Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Products & Services
        • 7.3.1.2.2. By Application
    • 7.3.2. Germany Large Molecule Bioanalytical Technologies Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Products & Services
        • 7.3.2.2.2. By Application
    • 7.3.3. United Kingdom Large Molecule Bioanalytical Technologies Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Products & Services
        • 7.3.3.2.2. By Application
    • 7.3.4. Italy Large Molecule Bioanalytical Technologies Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Products & Services
        • 7.3.4.2.2. By Application
    • 7.3.5. Spain Large Molecule Bioanalytical Technologies Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Products & Services
        • 7.3.5.2.2. By Application

8. Asia-Pacific Large Molecule Bioanalytical Technologies Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Products & Services
    • 8.2.2. By Application
    • 8.2.3. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Large Molecule Bioanalytical Technologies Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Products & Services
        • 8.3.1.2.2. By Application
    • 8.3.2. India Large Molecule Bioanalytical Technologies Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Products & Services
        • 8.3.2.2.2. By Application
    • 8.3.3. South Korea Large Molecule Bioanalytical Technologies Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Products & Services
        • 8.3.3.2.2. By Application
    • 8.3.4. Japan Large Molecule Bioanalytical Technologies Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Products & Services
        • 8.3.4.2.2. By Application
    • 8.3.5. Australia Large Molecule Bioanalytical Technologies Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Products & Services
        • 8.3.5.2.2. By Application

9. South America Large Molecule Bioanalytical Technologies Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Products & Services
    • 9.2.2. By Application
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Large Molecule Bioanalytical Technologies Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Products & Services
        • 9.3.1.2.2. By Application
    • 9.3.2. Argentina Large Molecule Bioanalytical Technologies Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Products & Services
        • 9.3.2.2.2. By Application
    • 9.3.3. Colombia Large Molecule Bioanalytical Technologies Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Products & Services
        • 9.3.3.2.2. By Application

10. Middle East and Africa Large Molecule Bioanalytical Technologies Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Products & Services
    • 10.2.2. By Application
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Large Molecule Bioanalytical Technologies Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Products & Services
        • 10.3.1.2.2. By Application
    • 10.3.2. Saudi Arabia Large Molecule Bioanalytical Technologies Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Products & Services
        • 10.3.2.2.2. By Application
    • 10.3.3. UAE Large Molecule Bioanalytical Technologies Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Products & Services
        • 10.3.3.2.2. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Porters Five Forces Analysis

  • 13.1. Competition in the Industry
  • 13.2. Potential of New Entrants
  • 13.3. Power of Suppliers
  • 13.4. Power of Customers
  • 13.5. Threat of Substitute Products

14. Competitive Landscape

  • 14.1. Intertek Group plc
    • 14.1.1. Business Overview
    • 14.1.2. Company Snapshot
    • 14.1.3. Products & Services
    • 14.1.4. Financials (As Reported)
    • 14.1.5. Recent Developments
    • 14.1.6. Key Personnel Details
    • 14.1.7. SWOT Analysis
  • 14.2. F. Hoffmann-La Roche Ltd
  • 14.3. Bio-Rad Laboratories, Inc.
  • 14.4. Solvias
  • 14.5. Bio-Techne
  • 14.6. Waters Corporation
  • 14.7. Verder Scientific GmbH & Co. KG
  • 14.8. Charles River Laboratories
  • 14.9. Merck KGaA
  • 14.10. Cergentis B.V.

15. Strategic Recommendations

16. About Us & Disclaimer